Multi-tiered screening and diagnosis strategy for COVID-19: a model for sustainable testing capacity in response to pandemic

@article{Pulia2020MultitieredSA,
  title={Multi-tiered screening and diagnosis strategy for COVID-19: a model for sustainable testing capacity in response to pandemic},
  author={M. Pulia and T. P. O'brien and P. Hou and Andrew J Schuman and R. Sambursky},
  journal={Annals of Medicine},
  year={2020},
  volume={52},
  pages={207 - 214}
}
  • M. Pulia, T. P. O'brien, +2 authors R. Sambursky
  • Published 2020
  • Medicine
  • Annals of Medicine
  • Abstract Coronavirus disease 2019 (COVID-19), caused by novel enveloped single stranded RNA coronavirus (SARS-CoV-2), is responsible for an ongoing global pandemic. While other countries deployed widespread testing as an early mitigation strategy, the U.S. experienced delays in development and deployment of organism identification assays. As such, there is uncertainty surrounding disease burden and community spread, severely hampering containment efforts. COVID-19 illuminates the need for a… CONTINUE READING
    COVID-19: molecular diagnostics overview
    1
    Validation and Performance Comparison of Three SARS-CoV-2 Antibody Assays
    7

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 54 REFERENCES
    Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
    185
    Challenges presented by MERS corona virus, and SARS corona virus to global health
    15
    Clinical diagnosis of 8274 samples with 2019-novel coronavirus in Wuhan
    47
    Supporting the Health Care Workforce During the COVID-19 Global Epidemic.
    207